<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: liver toxicity</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Predicting liver injury in paracetamol overdose patients</title>
   	 <description>Scientists at the University of Liverpool have identified molecules in the blood that could help predict the risk of a patient developing liver injury eight hours after a paracetamol overdose.</description>
     <link>http://medicalxpress.com/news/2013-02-liver-injury-paracetamol-overdose-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 22 Feb 2013 08:20:01 EST</pubDate>
	 <guid isPermaLink="false">news280742775</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/predictingli.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA approves juxtapid for rare cholesterol disorder</title>
   	 <description>(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat diet and other lipid lowering treatments, according to a Dec. 26 press release.</description>
     <link>http://medicalxpress.com/news/2012-12-fda-juxtapid-rare-cholesterol-disorder.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 27 Dec 2012 13:52:33 EST</pubDate>
	 <guid isPermaLink="false">news275838595</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdaapprovesj.jpg" width="90" height="90" />
</item>
<item>
     <title>Dietary supplements can cause liver injury, warns expert</title>
   	 <description>Dose-dependent (acetaminophen) and idiosyncratic drug-induced liver injuries (DILI) are the leading cause of acute liver failure in the United States and are responsible for approximately 50 percent of all reported cases.</description>
     <link>http://medicalxpress.com/news/2012-10-dietary-supplements-liver-injury-expert.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 29 Oct 2012 11:00:15 EST</pubDate>
	 <guid isPermaLink="false">news270725970</guid>
	 
</item>
<item>
     <title>New drug protects neurons in Parkinson's patients</title>
   	 <description>(Medical Xpress)—Scientists at Emory University School of Medicine have identified a compound that boosts levels of a survival factor in neurons threatened by Parkinson's disease.</description>
     <link>http://medicalxpress.com/news/2012-09-drug-neurons-parkinson-patients.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Wed, 05 Sep 2012 07:13:07 EST</pubDate>
	 <guid isPermaLink="false">news266047977</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newdrugprote.jpg" width="90" height="90" />
</item>
<item>
     <title>Acetaminophen overdoses in children can be life-threatening but are avoidable</title>
   	 <description>Acetaminophen, a widely available over-the-counter medication, can cause liver toxicity in children if doses are exceeded, and more public education is needed to warn of potential adverse effects, states an article published in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2012-06-acetaminophen-overdoses-children-life-threatening.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 04 Jun 2012 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news258026343</guid>
	 
</item>
<item>
     <title>New fractionated dosing regimen for anticancer drug significantly improves outcomes for older leukemia patients</title>
   	 <description>Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. These are the conclusions of an Article published Online First by The Lancet, written by Professor Sylvie Castaigne, Centre Hospitalier de Versailles, France, and colleagues.</description>
     <link>http://medicalxpress.com/news/2012-04-fractionated-dosing-regimen-anticancer-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 Apr 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news252768318</guid>
	 
</item>
<item>
     <title>FDA panel backs Glaxo drug for rare sarcoma cancer</title>
   	 <description>(AP) --  A panel of cancer experts overwhelmingly backed the approval of a GlaxoSmithKline drug for a rare type of tumor, noting there are few other treatment options for patients.</description>
     <link>http://medicalxpress.com/news/2012-03-fda-panel-glaxo-drug-rare.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 20 Mar 2012 14:15:15 EST</pubDate>
	 <guid isPermaLink="false">news251471708</guid>
	 
</item>
<item>
     <title>Researchers find novel way to prevent drug-induced liver injury</title>
   	 <description>Massachusetts General Hospital (MGH) investigators have developed a novel strategy to protect the liver from drug-induced injury and improve associated drug safety. In their report receiving advance online publication in the journal Nature Biotechnology, the team reports that inhibition of a type of cell-to-cell communication can protect against the damage caused by liver-toxic drugs such as acetaminophen.</description>
     <link>http://medicalxpress.com/news/2012-01-drug-induced-liver-injury.html</link>
	 <category>Medical research</category>
	 <pubDate>Sun, 15 Jan 2012 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news245852861</guid>
	 
</item>
<item>
     <title>Artificial intestine to treat youths' bowel disorder</title>
   	 <description>(Medical Xpress) -- A tiny 3-D collagen &quot;scaffold&quot; developed in a Cornell lab could prove a lifesaver for those who have lost parts of their intestine.</description>
     <link>http://medicalxpress.com/news/2011-12-artificial-intestine-youths-bowel-disorder.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 09 Dec 2011 03:54:58 EST</pubDate>
	 <guid isPermaLink="false">news242625282</guid>
	 
</item>
<item>
     <title>Scientists identify key protein linked to acute liver failure</title>
   	 <description>New research from the Keck School of Medicine of the University of Southern California (USC) may help prevent damage to the liver caused by drugs like acetaminophen and other stressors.</description>
     <link>http://medicalxpress.com/news/2011-09-scientists-key-protein-linked-acute.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 07 Sep 2011 15:37:45 EST</pubDate>
	 <guid isPermaLink="false">news234628650</guid>
	 
</item>
<item>
     <title>Colon cleansing has no benefit but many side effects including vomiting and death</title>
   	 <description>Colon cleansing -  it's been described as a natural way to enhance well-being, but Georgetown University doctors say there's no evidence to back that claim.  In fact, their review of scientific literature, published today in the August issue of The Journal of Family Practice, demonstrates that colon cleansing can cause side effects ranging from cramping to renal failure and death.</description>
     <link>http://medicalxpress.com/news/2011-08-colon-cleansing-benefit-side-effects.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Aug 2011 05:00:01 EST</pubDate>
	 <guid isPermaLink="false">news231391462</guid>
	 
</item>


</channel>
</rss>
